EGFR Inhibitor

Managing adverse effects of NSCLC treatment

Managing adverse effects of NSCLC treatment

EGFR inhibitors are widely used to treat metastatic NSCLC; however, they can cause various adverse effects that differ from those caused by traditional intravenous chemotherapy.

Chemotherapy better for a subset of patients with advanced lung cancer

By

Among patients with advanced NSCLC without an EGFR mutation, conventional chemotherapy compared with treatment using tyrosine kinase inhibitors targeting EGFR was associated with improvement in survival without progression of the cancer.

New patterns of dermatologic toxicity with radiation and EGFR blockade

New patterns of dermatologic toxicity with radiation and EGFR blockade

By

Emerging combination radiotherapy regimens are improving overall survival; however, associated dermatologic toxicities pose unique challenges.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs